 
	
 
                                    
                                Nexvax2 was developed by Nexpep Pty, Ltd., a company in Melbourne, Australia. It is based on their findings that only three peptides are responsible for eliciting the majority of the T cell response that goes on to destroy the intestines of celiac patients. HLA molecules function to present these toxic peptides to T cells; this presentation is what activates the T cells, instigating the inflammatory response. Thus...
- Read Full Article...
- 1 comment
- 18,750 views
 Like
					
					Like
					
						 Thanks
					
					Thanks
					
						 Haha
					
					Haha
					
						 Confused
					
					Confused
					
						 Sad
					
					Sad
					
						 Upvote
					
					Upvote
					
						





 
	.thumb.jpg.d8ccdbb71dd5d276bacf435aa9f4427d.jpg)
